Linical Co Ltd
TSE:2183

Watchlist Manager
Linical Co Ltd Logo
Linical Co Ltd
TSE:2183
Watchlist
Price: 330 JPY 0.61% Market Closed
Market Cap: 7.5B JPY
Have any thoughts about
Linical Co Ltd?
Write Note

Linical Co Ltd
Investor Relations

Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. The company is headquartered in Osaka, Osaka-Fu and currently employs 845 full-time employees. The company went IPO on 2008-10-27. The firm operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Kazuhiro Hatano
President, CEO, Chief Strategy Officer, Chief Commercial Officer & Representative Director
No Bio Available
Mr. Akihiro Takahashi
Chief Financial Officer
No Bio Available
Tokuno Masayoshi
Chief Information Officer
No Bio Available
Mr. Jun Kawai
Chief Administrative Officer
No Bio Available
Ms. Shiori Yamaguchi
Chief Compliance Officer
No Bio Available
Mr. Keigo Tsujimoto
Executive Officer & Chief Project Officer
No Bio Available
Mr. Masaya Miyazaki
Chief Asia Pacific Officer
No Bio Available
Ms. Clareece West
President & Chief Commercial Officer of Americas & Europe
No Bio Available
Dr. Tracy Goeken M.D.
Chief Medical Officer
No Bio Available
Satoru Toyota
Executive Officer & Head of Oncology Business Unit (HQ, Japan)
No Bio Available

Contacts

Address
OSAKA-FU
Osaka
10F, Shin-Osaka Brick Bldg., 1-6-1, Miyahara, Yodogawa-ku
Contacts
+81661502478.0
www.linical.co.jp
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.